Physician profile
Shirley Chio
NPI 1871960021
$1,207.15
in general payments reported to CMS, 2019-2025
16 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.86 · 2022: $148 · 2023: $251 · 2024: $517 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $316.82 | 2023-2024 | Rocklatan, Argos, Clareon |
| Bausch & Lomb Americas INC. | $129.59 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Dompe US, INC. | $125.67 | 2024-2025 | Oxervate |
| Thea Pharma INC. | $123.77 | 2022-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $107.25 | 2024-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $80.91 | 2024-2025 | Xdemvy |
| Abbvie INC. | $78.37 | 2022-2023 | Botox |
| Novartis Pharmaceuticals Corporation | $52.94 | 2023 | |
| Sun Pharmaceutical Industries INC. | $30.64 | 2022 | |
| Harrow Eye, LLC | $28.69 | 2024 | Vevye |
| Optos, INC. | $25.04 | 2022 | |
| Amgen INC. | $23.07 | 2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $22.86 | 2021 | |
| Astellas Pharma US INC | $22.67 | 2024 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $21.38 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Chio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.